Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Expression of a constitutively active mutant of M-Ras in normal bone marrow is sufficient for induction of a malignant mastocytosis/mast cell leukemia, distinct from the histiocytosis/monocytic leukemia induced by expression of activated H-Ras

Oncogene volume 24, pages 2330–2342 (2005)Cite this article

Abstract

Expression of constitutively activated M-Ras in normal murine bone-marrow cells was sufficient to induce the factor-independent, in vitro growth and differentiation of colonies of macrophages and neutrophils, and the generation of immortal lines of factor-independent mast cells, and, upon in vivo injection of the transduced cells, a fatal mastocytosis/mast-cell leukemia. In contrast, expression of constitutively activated H-Ras in bone-marrow cells resulted in the in vitro growth, in the absence of exogenous factors, of colonies that contained only macrophages and of lines of cells resembling dendritic cells, and, upon in vivo injection of the transduced cells, a fatal histiocytosis/monocytic leukemia. Macrophages generated by bone-marrow cells expressing activated M-Ras or activated H-Ras differed morphologically, the latter appearing more activated, a difference abrogated by an inhibitor of Erk activation. Inhibition of either Erk or PI3 kinase blocked the capacity of both activated M-Ras and activated H-Ras to support proliferation and viability. However, inhibition of p38 MAPK activity suppressed proliferation of bone-marrow cells expressing activated H-Ras, but enhanced that of bone-marrow cells expressing activated M-Ras. Thus, expression of either activated M-Ras or H-Ras in normal hematopoietic cells was sufficient for transformation but each resulted in the generation of distinct lineages of cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Andrejauskas E and Moroni C . (1989). EMBO J., 8, 2575–2581.

  • Bashey A, Gill R, Levi S, Farr CJ, Clutterbuck R, Millar JL, Pragnell IB and Marshall CJ . (1992). Blood, 79, 981–989.

  • Bos JL . (1989). Cancer Res., 49, 4682–4689.

  • Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ and Der CJ . (1998). Oncogene, 17, 1395–1413.

  • Chen CY, Del Gatto-Konczak F, Wu Z and Karin M . (1998). Science, 280, 1945–1949.

  • Chen G, Hitomi M, Han J and Stacey DW . (2000). J. Biol. Chem., 275, 38973–38980.

  • Cowley S, Paterson H, Kemp P and Marshall CJ . (1994). Cell, 77, 841–852.

  • Danial NN, Losman JA, Lu T, Yip N, Krishnan K, Krolewski J, Goff SP, Wang JY and Rothman PB . (1998). Mol. Cell. Biol., 18, 6795–6804.

  • Darley RL and Burnett AK . (1999). Exp. Hematol., 27, 1599–1608.

  • Darley RL, Hoy TG, Baines P, Padua RA and Burnett AK . (1997). J. Exp. Med., 185, 1337–1347.

  • Darley RL, Pearn L, Omidvar N, Sweeney M, Fisher J, Phillips S, Hoy T and Burnett AK . (2002). Blood, 100, 4185–4192.

  • Dunbar CE, Crosier PS and Nienhuis AW . (1991). Oncogene Res., 6, 39–51.

  • Duronio V, Welham MJ, Abraham S, Dryden P and Schrader JW . (1992). Proc. Natl. Acad. Sci. USA, 89, 1587–1591.

  • Ehrhardt A, David MD, Ehrhardt GR and Schrader JW . (2004). Mol. Cell. Biol., 24, 6311–6323.

  • Ehrhardt A, Ehrhardt GR, Guo X and Schrader JW . (2002). Exp. Hematol., 30, 1089–1106.

  • Ehrhardt GR, Korherr C, Wieler JS, Knaus M and Schrader JW . (2001). Oncogene, 20, 188–197.

  • Ehrhardt GR, Leslie KB, Lee F, Wieler JS and Schrader JW . (1999). Blood, 94, 2433–2444.

  • Foltz IN, Lee JC, Young PR and Schrader JW . (1997). J. Biol. Chem., 272, 3296–3301.

  • Foltz IN and Schrader JW . (1997). Blood, 89, 3092–3096.

  • Gao X, Satoh T, Liao Y, Song C, Hu CD, Kariya Ki K and Kataoka T . (2001). J. Biol. Chem., 276, 42219–42225.

  • Gille H and Downward J . (1999). J. Biol. Chem., 274, 22033–22040.

  • Gold MR, Duronio V, Saxena SP, Schrader JW and Aebersold R . (1994). J. Biol. Chem., 269, 5403–5412.

  • Grill B and Schrader JW . (2002). Blood, 100, 3183–3192.

  • Guo X, Gerl RE and Schrader JW . (2003). J. Biol. Chem., 278, 22237–22242.

  • Gupta AK, Bernhard EJ, Bakanauskas VJ, Cerniglia GJ, Muschel RJ and McKenna G . (2003). Cancer Biol. Ther., 2, 73–75.

  • Gurish MF, Pear WS, Stevens RL, Scott ML, Sokol K, Ghildyal N, Webster MJ, Hu X, Austen KF, Baltimore D and Friend DS . (1995). Immunity, 3, 175–186.

  • Hamad NM, Banik SS and Counter CM . (2002). Oncogene, 21, 7121–7125.

  • Hawley RG, Fong AZ, Ngan BY and Hawley TS . (1995). Oncogene, 11, 1113–1123.

  • Hibi S, Lohler J, Friel J, Stocking C and Ostertag W . (1993). Blood, 81, 1841–1848.

  • Ingram DA, Hiatt K, King AJ, Fisher L, Shivakumar R, Derstine C, Wenning MJ, Diaz B, Travers JB, Hood A, Marshall M, Williams DA and Clapp DW . (2001). J. Exp. Med., 194, 57–69.

  • Ingram DA, Yang FC, Travers JB, Wenning MJ, Hiatt K, New S, Hood A, Shannon K, Williams DA and Clapp DW . (2000). J. Exp. Med., 191, 181–188.

  • Jin DI, Jameson SB, Reddy MA, Schenkman D and Ostrowski MC . (1995). Mol. Cell. Biol., 15, 693–703.

  • Karlsson R, Engstrom M, Jonsson M, Karlberg P, Pronk CJ, Richter J and Jonsson JI . (2003). J. Leukoc. Biol., 74, 923–931.

  • Kimmelman A, Tolkacheva T, Lorenzi MV, Osada M and Chan AM . (1997). Oncogene, 15, 2675–2685.

  • Kimmelman AC, Osada M and Chan AM . (2000). Oncogene, 19, 2014–2022.

  • Levings MK, Bessette DC and Schrader JW . (1999). Blood, 93, 3694–3702.

  • Lin A, Minden A, Martinetto H, Claret FX, Lange-Carter C, Mercurio F, Johnson GL and Karin M . (1995). Science, 268, 286–290.

  • Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M and Lowe SW . (1998). Genes Dev., 12, 3008–3019.

  • Louahed J, Grasso L, De Smet C, Van Roost E, Wildmann C, Nicolaides NC, Levitt RC and Renauld JC . (1999). Blood, 94, 1701–1710.

  • MacKenzie KL, Dolnikov A, Millington M, Shounan Y and Symonds G . (1999). Blood, 93, 2043–2056.

  • MacLeod AR, Rouleau J and Szyf M . (1995). J. Biol. Chem., 270, 11327–11337.

  • Maher J, Colonna F, Baker D, Luzzatto L and Roberts I . (1994). Exp. Hematol., 22, 8–12.

  • Matsuguchi T and Kraft AS . (1998). Oncogene, 17, 2701–2709.

  • Matsumoto K, Asano T and Endo T . (1997). Oncogene, 15, 2409–2417.

  • McFall A, Ulku A, Lambert QT, Kusa A, Rogers-Graham K and Der CJ . (2001). Mol. Cell. Biol., 21, 5488–5499.

  • Ming XF, Kaiser M and Moroni C . (1998). EMBO J., 17, 6039–6048.

  • Ming XF, Stoecklin G, Lu M, Looser R and Moroni C . (2001). Mol. Cell. Biol., 21, 5778–5789.

  • Nair AP, Diamantis ID, Conscience JF, Kindler V, Hofer P and Moroni C . (1989). Mol. Cell. Biol., 9, 1183–1190.

  • Nair AP, Hirsch HH and Moroni C . (1992). Oncogene, 7, 1963–1972.

  • Ohba Y, Mochizuki N, Yamashita S, Chan AM, Schrader JW, Hattori S, Nagashima K and Matsuda M . (2000). J. Biol. Chem., 275, 20020–20026.

  • Oki S, Limnander A, Danial NN and Rothman PB . (2002). Blood, 100, 966–973.

  • Okuda K, Ernst TJ and Griffin JD . (1994). J. Biol. Chem., 269, 24602–24607.

  • Pacold ME, Suire S, Perisic O, Lara-Gonzalez S, Davis CT, Walker EH, Hawkins PT, Stephens L, Eccleston JF and Williams RL . (2000). Cell, 103, 931–943.

  • Pierce JH and Aaronson SA . (1982). J. Exp. Med., 156, 873–887.

  • Pierce JH and Aaronson SA . (1985). Mol. Cell. Biol., 5, 667–674.

  • Pruitt K, Pruitt WM, Bilter GK, Westwick JK and Der CJ . (2002). J. Biol. Chem., 277, 31808–31817.

  • Quilliam LA, Castro AF, Rogers-Graham KS, Martin CB, Der CJ and Bi C . (1999). J. Biol. Chem., 274, 23850–23857.

  • Rausch O and Marshall CJ . (1997). Mol. Cell. Biol., 17, 1170–1179.

  • Rausch O and Marshall CJ . (1999). J. Biol. Chem., 274, 4096–4105.

  • Rebhun JF, Castro AF and Quilliam LA . (2000). J. Biol. Chem., 275, 34901–34908.

  • Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A and Downward J . (1997). Cell, 89, 457–467.

  • Satoh T, Nakafuku M, Miyajima A and Kaziro Y . (1991). Proc. Natl. Acad. Sci. USA, 88, 3314–3318.

  • Sheng H, Shao J and DuBois RN . (2001). J. Biol. Chem., 276, 14498–14504.

  • Shields JM, Pruitt K, McFall A, Shaub A and Der CJ . (2000). Trends Cell Biol., 10, 147–154.

  • Skorski T, Szczylik C, Ratajczak MZ, Malaguarnera L, Gewirtz AM and Calabretta B . (1992). J. Exp. Med., 175, 743–750.

  • Terada K, Kaziro Y and Satoh T . (1995). J. Biol. Chem., 270, 27880–27886.

  • Terada K, Kaziro Y and Satoh T . (1997). J. Biol. Chem., 272, 4544–4548.

  • Tuveson DA, Shaw AT, Willis NA, Silver DP, Jackson EL, Chang S, Mercer KL, Grochow R, Hock H, Crowley D, Hingorani SR, Zaks T, King C, Jacobetz MA, Wang L, Bronson RT, Orkin SH, DePinho RA and Jacks T . (2004). Cancer Cell, 5, 375–387.

  • Urano T, Emkey R and Feig LA . (1996). EMBO J., 15, 810–816.

  • Varnum-Finney B, Xu L, Brashem-Stein C, Nourigat C, Flowers D, Bakkour S, Pear WS and Bernstein ID . (2000). Nat. Med., 6, 1278–1281.

  • von Ruden T, Kandels S, Radaszkiewicz T, Ullrich A and Wagner EF . (1992). Blood, 79, 3145–3158.

  • Ward KR, Zhang KX, Somasiri AM, Roskelley CD and Schrader JW . (2004). Oncogene, 23, 1187–1196.

  • Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer SM, Zlobin A, Osborne BA, Gottipati S, Aster JC, Hahn WC, Rudolf M, Siziopikou K, Kast WM and Miele L . (2002). Nat. Med., 8, 979–986.

  • Welham MJ, Duronio V, Sanghera JS, Pelech SL and Schrader JW . (1992). J. Immunol., 149, 1683–1693.

  • White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M and Wigler MH . (1995). Cell, 80, 533–541.

  • Winzen R, Kracht M, Ritter B, Wilhelm A, Chen CY, Shyu AB, Muller M, Gaestel M, Resch K and Holtmann H . (1999). EMBO J., 18, 4969–4980.

  • Wolthuis RM and Bos JL . (1999). Curr. Opin. Genet. Dev., 9, 112–117.

  • Wolthuis RM, de Ruiter ND, Cool RH and Bos JL . (1997). EMBO J., 16, 6748–6761.

  • Zhang KX, Ward KR and Schrader JW . (2004). Mol. Cancer Res., 2, 242–255.

  • Zhu J, Woods D, McMahon M and Bishop JM . (1998). Genes Dev., 12, 2997–3007.

Download references

Acknowledgements

We thank Dr H Ziltener for providing the anti-IL-3 and 9E10 antibodies and Mrs H Merkens for technical assistance. This project was supported by a grant from the Canadian Institutes of Health Research (CIHR).

Author information

Authors and Affiliations

  1. The Biomedical Research Centre, University of British Columbia, Vancouver, BC, Canada, V6T1Z3

    Xuecui Guo, Kasmintan A Schrader, Yaoxian Xu & John W Schrader

Authors
  1. Xuecui Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kasmintan A Schrader
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yaoxian Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John W Schrader
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John W Schrader.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guo, X., Schrader, K., Xu, Y. et al. Expression of a constitutively active mutant of M-Ras in normal bone marrow is sufficient for induction of a malignant mastocytosis/mast cell leukemia, distinct from the histiocytosis/monocytic leukemia induced by expression of activated H-Ras. Oncogene 24, 2330–2342 (2005). https://doi.org/10.1038/sj.onc.1208441

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208441

Keywords

This article is cited by

Search

Advanced search

Quick links